Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Padma Sathyanarayana"'
Autor:
Ramkumar Krishnamurthy, Absalon D. Gutierrez, Padma Sathyanarayana, Erica V. Gonzalez, M. Jogi, Mandeep Bajaj, Lawrence Chan, Raja Muthupillai, Susan L. Samson
Publikováno v:
Diabetologia. 54:3093-3100
Systemic fibroblast growth factor (FGF)21 levels and hepatic FGF21 production are increased in non-alcoholic fatty liver disease patients, suggesting FGF21 resistance. We examined the effects of exenatide on FGF21 in patients with type 2 diabetes and
Autor:
Mandeep Bajaj, Sanjeev Choudhary, Ronald G. Tilton, Vadim Sherman, Srijita Banerjee, Sadeka Shahani, Yanhua Zhao, Padma Sathyanarayana, Sandeep Sinha
Publikováno v:
Endocrinology. 152:3622-3627
Enhanced levels of nuclear factor (NF)-κB-inducing kinase (NIK), an upstream kinase in the NF-κB pathway, have been implicated in the pathogenesis of chronic inflammation in diabetes. We investigated whether increased levels of NIK could induce ske
Autor:
Lawrence J. Mandarino, Lily Q. Dong, Zhengping Yi, Rachele Berria, C. Christ-Roberts, K. Fujiwara, Padma Sathyanarayana, Mandeep Bajaj, J. Finlayson, H. Hwang, Vadim Sherman, E. De Filippis, C. Meyer, Sadeka Shahani, R. M. Holmes
Publikováno v:
Diabetologia
Aims/hypothesis The adiponectin signalling pathway is largely unknown, but recently the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1), has been shown to interact directly with a
Autor:
Yochai Birnbaum, Padma Sathyanarayana, Somasekhar Konduru, Absalon D. Gutierrez, Mandeep Bajaj, Yumei Ye
Publikováno v:
Atherosclerosis. 223(1)
Arachidonic acid-derived eicosanoids (lipoxins and 15-epilipoxins) have a major role in resolution of inflammation. 15-epi-lipoxin A(4) (15-epi-LXA(4)) is a lipid mediator with strong anti-inflammatory and inflammation-resolving effects. We examined
Autor:
Raja Muthupillai, Mandeep Bajaj, Padma Sathyanarayana, Susan L. Samson, Medhavi Jogi, Ramkumar Krishnamurthy
Publikováno v:
Obesity (Silver Spring, Md.). 19(12)
We examined the effects of combined pioglitazone (peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist) and exenatide (GLP-1 receptor agonist) therapy on hepatic fat content and plasma adiponectin levels in patients with type 2 diabetes (T
Autor:
Susan L Samson, Erica V Gonzalez, Christie Espiritu, Padma Sathyanarayana, Pradip Saha, Mandeep Bajaj, Lawrence Chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::418db40ae45f515d509c38711187065b
https://doi.org/10.1210/endo-meetings.2011.part3.p5.p2-483
https://doi.org/10.1210/endo-meetings.2011.part3.p5.p2-483
Autor:
Devjit Tripathy, Yidong Bai, Lokendra Kumar Sharma, Muhammad A. Abdul-Ghani, Victoria E. Centonze, Alberto O. Chavez, Rucha Jani, Adriana Monroy, Franco Folli, Dawn K. Coletta, Padma Sathyanarayana, Ralph A. DeFronzo, Cristopher P. Jenkinson, Subhash Kamath
Publikováno v:
The Journal of clinical endocrinology and metabolism. 95(1)
Context: Mitochondrial dysfunction has been proposed as an underlying mechanism in the pathogenesis of insulin resistance and type 2 diabetes mellitus. Objective: To determine whether mitochondrial dysfunction plays a role in the free fatty acid (FFA